Gene Editing
5 theme stocks in the Gene Editing theme, with a sum of listed market caps of $197.16B. On average they are up 2.01% today and up 16% over the past year.
Stocks5
Sum of listed market caps$197.16B
Average move today▲ 2.01%
Average 1-year return▲ 16.5%
Median P/E34.5
Avg dividend yield0.58%
Leading today
Biggest gainers in this group
Lagging today
Biggest decliners in this group
Breadth
How many members are up or down right now
5 advancing · 0 declining · 0 unchanged
All 5 stocks, largest first
| # | Stock | Price | Day | 1 year | Market cap | P/E (TTM) | Yield | 52-week range |
|---|---|---|---|---|---|---|---|---|
| 1 | VRTX Vertex Pharmaceuticals | $547.09 | ▲ 0.85% | ▲ 33.6% | $138.71B | 35.2 | – | |
| 2 | A Agilent Technologies | $174.76 | ▲ 1.73% | ▲ 19.8% | $49.27B | 34.5 | 0.58% | |
| 3 | CRSP CRISPR Therapeutics | $50.07 | ▲ 3.11% | ▼ 9.2% | $4.86B | – | – | |
| 4 | BEAM Beam Therapeutics | $26.41 | ▲ 2.09% | ▲ 18.9% | $2.73B | – | – | |
| 5 | NTLA Intellia Therapeutics | $11.35 | ▲ 2.25% | ▲ 19.2% | $1.59B | – | – |
"1 year" is the price change over the past 365 days. P/E is trailing. For reference only, not investment advice.